{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:39:16Z","timestamp":1792100356623,"version":"4.4.0"},"reference-count":98,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NIH National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL156779"],"award-info":[{"award-number":["1R01HL156779"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["4R00AI151094"],"award-info":[{"award-number":["4R00AI151094"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI184179"],"award-info":[{"award-number":["1R01AI184179"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5R01AI169588"],"award-info":[{"award-number":["5R01AI169588"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite effective chemotherapy, tuberculosis (TB) survivors experience excess morbidity and mortality associated with long-term sequelae. Ventilatory defects, such as airflow obstruction, restriction, and mixed patterns, have been reported in over half of treated pulmonary TB cases. Spirometry alone underestimates burden, with impaired diffusing capacity, gas trapping, heterogeneous airway, and parenchymal damage on lung imaging, functional impairment, and persistent respiratory symptoms commonly reported. Bronchiectasis and chronic pulmonary aspergillosis are also common and occur in approximately one-third of TB survivors. Beyond the lungs, observational data consistently link TB to elevated cardiovascular disease risk, including myocardial infarction, stroke, and peripheral arterial disease, during and after TB treatment. Tuberculosis is also associated with increased lung cancer risk independent of smoking exposure, with adenocarcinoma, squamous cell, and small cell carcinomas commonly reported. While ongoing research suggests a key role of a dysfunctional host inflammatory response in the pathogenesis of TB sequelae, several knowledge gaps persist. Key among them include identifying individuals at highest risk of TB sequelae, defining clinically relevant phenotypes, endotypes, and natural history trajectories, and identifying prognostic biomarkers and potentially modifiable targets for immunomodulatory therapies. In this narrative review, we discuss key long-term sequelae of pulmonary TB, highlight research priorities, and propose a way forward through new research initiatives such as the \u201cLong TB Study.\u201d<\/jats:p>","DOI":"10.1093\/cid\/ciag123","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:43:53Z","timestamp":1772109833000},"page":"S60-S67","source":"Crossref","is-referenced-by-count":3,"title":["Long-term Sequelae of Pulmonary Tuberculosis: A Narrative Review"],"prefix":"10.1093","volume":"82","author":[{"given":"Akshay N","family":"Gupte","sequence":"first","affiliation":[{"name":"Department of Global Health, Boston University School of Public Health , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alix","family":"Boisson-Walsh","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Rutgers University Medical School , Newark, New Jersey ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moises A","family":"Huaman","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Cincinnati College of Medicine , Cincinnati, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajita","family":"Bhavaraju","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Rutgers University Medical School , Newark, New Jersey ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Global Health, Boston University School of Public Health , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hom","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Rutgers University Medical School , Newark, New Jersey ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold","family":"Ellner","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Rutgers University Medical School , Newark, New Jersey ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8970-7306","authenticated-orcid":false,"given":"Hardy","family":"Kornfeld","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, UMass Chan Medical School , Worcester, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"2026041316530684000_ciag123-B1","volume-title":"Global TB report","year":"2024"},{"key":"2026041316530684000_ciag123-B2","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1473-3099(19)30309-3","article-title":"Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis","volume":"19","author":"Romanowski","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2026041316530684000_ciag123-B3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5588\/ijtldopen.23.0619","article-title":"Perspectives from the 2(nd) International Post-Tuberculosis Symposium: mobilising advocacy and research for improved outcomes","volume":"1","author":"Allwood","year":"2024","journal-title":"IJTLD Open"},{"key":"2026041316530684000_ciag123-B4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5588\/ijtld.22.0514","article-title":"Post-TB health and wellbeing","volume":"27","author":"Nightingale","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026041316530684000_ciag123-B5","doi-asserted-by":"crossref","first-page":"e1679","DOI":"10.1016\/S2214-109X(21)00367-3","article-title":"Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae","volume":"9","author":"Menzies","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2026041316530684000_ciag123-B6","doi-asserted-by":"crossref","first-page":"e5080","DOI":"10.1371\/journal.pone.0005080","article-title":"Personal and societal health quality lost to tuberculosis","volume":"4","author":"Miller","year":"2009","journal-title":"PLoS One"},{"key":"2026041316530684000_ciag123-B7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1164\/rccm.202411-2213OC","article-title":"Contribution of posttuberculosis sequelae to life-years lost from tuberculosis disease in the United States, 2015\u20132019","volume":"211","author":"Menzies","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026041316530684000_ciag123-B8","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S1473-3099(20)30919-1","article-title":"Quantifying the global number of tuberculosis survivors: a modelling study","volume":"21","author":"Dodd","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2026041316530684000_ciag123-B9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.5588\/ijtld.20.0067","article-title":"Post-tuberculosis lung health: perspectives from the First International Symposium","volume":"24","author":"Allwood","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026041316530684000_ciag123-B10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/095952874602900113","article-title":"On the capacity of the lungs, and on the respiratory functions, with a view of establishing a precise and easy method of detecting disease by the spirometer","volume":"MCT-29","author":"Hutchinson","year":"1846","journal-title":"Med Chir Trans"},{"key":"2026041316530684000_ciag123-B11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1378\/chest.15-1045","article-title":"The vital capacity is vital: epidemiology and clinical significance of the restrictive spirometry pattern","volume":"149","author":"Godfrey","year":"2016","journal-title":"Chest"},{"key":"2026041316530684000_ciag123-B12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1084\/jem.27.1.87","article-title":"Studies of lung volume: II. Tuberculous men","volume":"27","author":"Garvin","year":"1918","journal-title":"J Exp Med"},{"key":"2026041316530684000_ciag123-B13","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1183\/13993003.02325-2014","article-title":"Tuberculosis associates with both airflow obstruction and low lung function: BOLD results","volume":"46","author":"Amaral","year":"2015","journal-title":"Eur Respir J"},{"key":"2026041316530684000_ciag123-B14","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(25)00105-6","article-title":"Post-pulmonary tuberculosis lung function: a systematic review and meta-analysis","volume":"13","author":"Ratnakumar","year":"2025","journal-title":"The Lancet Global Health"},{"key":"2026041316530684000_ciag123-B15","doi-asserted-by":"crossref","first-page":"220221","DOI":"10.1183\/16000617.0221-2022","article-title":"Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people","volume":"32","author":"Ivanova","year":"2023","journal-title":"Eur Respir Rev"},{"key":"2026041316530684000_ciag123-B16","doi-asserted-by":"crossref","first-page":"e0000805","DOI":"10.1371\/journal.pgph.0000805","article-title":"Magnitude and factors associated with post-tuberculosis lung disease in low- and middle-income countries: a systematic review and meta-analysis","volume":"2","author":"Maleche-Obimbo","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"2026041316530684000_ciag123-B17","doi-asserted-by":"crossref","first-page":"101979","DOI":"10.1016\/j.eclinm.2023.101979","article-title":"Residual respiratory disability after successful treatment of pulmonary tuberculosis: a systematic review and meta-analysis","volume":"59","author":"Taylor","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2026041316530684000_ciag123-B18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2147\/COPD.S219731","article-title":"Transition from restrictive to obstructive lung function impairment during treatment and follow-up of active tuberculosis","volume":"15","author":"Allwood","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026041316530684000_ciag123-B19","doi-asserted-by":"crossref","first-page":"e0161176","DOI":"10.1371\/journal.pone.0161176","article-title":"A systematic review of the prevalence and pattern of imaging defined post-TB lung disease","volume":"11","author":"Meghji","year":"2016","journal-title":"PLoS One"},{"key":"2026041316530684000_ciag123-B20","doi-asserted-by":"crossref","first-page":"e1269","DOI":"10.1016\/S2214-109X(19)30327-4","article-title":"Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry","volume":"7","author":"Dhar","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2026041316530684000_ciag123-B21","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1093\/cid\/ciaf150","article-title":"A systematic review of chronic pulmonary aspergillosis among patients treated for pulmonary tuberculosis","volume":"81","author":"Madden","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026041316530684000_ciag123-B22","doi-asserted-by":"crossref","first-page":"e0217289","DOI":"10.1371\/journal.pone.0217289","article-title":"Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD","volume":"14","author":"Gupte","year":"2019","journal-title":"PLoS One"},{"key":"2026041316530684000_ciag123-B23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0954-6111(89)80031-9","article-title":"Chronic obstructive airways disease following treated pulmonary tuberculosis","volume":"83","author":"Willcox","year":"1989","journal-title":"Respir Med"},{"key":"2026041316530684000_ciag123-B24","doi-asserted-by":"crossref","first-page":"102898","DOI":"10.1016\/j.eclinm.2024.102898","article-title":"Risk factors associated with post-tuberculosis sequelae: a systematic review and meta-analysis","volume":"77","author":"Akalu","year":"2024","journal-title":"eClinicalMedicine"},{"key":"2026041316530684000_ciag123-B25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12879-023-08055-9","article-title":"Mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure","volume":"23","author":"Ordaz-V\u00e1zquez","year":"2023","journal-title":"BMC Infect Dis"},{"key":"2026041316530684000_ciag123-B26","doi-asserted-by":"crossref","first-page":"e0001788","DOI":"10.1371\/journal.pgph.0001788","article-title":"The effect of M. tuberculosis lineage on clinical phenotype","volume":"3","author":"Du","year":"2023","journal-title":"PLOS Glob Public Health"},{"key":"2026041316530684000_ciag123-B27","doi-asserted-by":"crossref","first-page":"e1007613","DOI":"10.1371\/journal.ppat.1007613","article-title":"Transmission phenotype of Mycobacterium tuberculosis strains is mechanistically linked to induction of distinct pulmonary pathology","volume":"15","author":"Verma","year":"2019","journal-title":"PLoS Pathog"},{"key":"2026041316530684000_ciag123-B28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cegh.2018.11.002","article-title":"The role of Mycobacterium tuberculosis lineages on lung tissue damage and TNF-\u03b1 level among tuberculosis patients, Indonesia","volume":"7","author":"Amin","year":"2019","journal-title":"Clin Epidemiol Glob Health"},{"key":"2026041316530684000_ciag123-B29","doi-asserted-by":"crossref","first-page":"EVIDe2400181","DOI":"10.1056\/EVIDe2400181","article-title":"Host-directed therapies for posttuberculosis lung disease","volume":"3","author":"Gupte","year":"2024","journal-title":"NEJM Evid"},{"key":"2026041316530684000_ciag123-B30","doi-asserted-by":"crossref","first-page":"2100905","DOI":"10.1183\/13993003.00905-2021","article-title":"Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study","volume":"59","author":"Gupte","year":"2022","journal-title":"Eur Respir J"},{"key":"2026041316530684000_ciag123-B31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ebiom.2015.11.040","article-title":"Matrix metalloproteinases in tuberculosis-immune reconstitution inflammatory syndrome and impaired lung function among advanced HIV\/TB co-infected patients initiating antiretroviral therapy","volume":"3","author":"Ravimohan","year":"2016","journal-title":"EBioMedicine"},{"key":"2026041316530684000_ciag123-B32","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/infdis\/jiad232","article-title":"Circulating biomarkers, FeNO, and lung function in patients with HIV and tuberculosis","volume":"229","author":"Maenetje","year":"2024","journal-title":"J Infect Dis"},{"key":"2026041316530684000_ciag123-B33","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/cid\/ciz898","article-title":"A common NLRC4 gene variant associates with inflammation and pulmonary function in human immunodeficiency virus and tuberculosis","volume":"71","author":"Ravimohan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026041316530684000_ciag123-B34","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nm.4177","article-title":"Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure","volume":"22","author":"Malherbe","year":"2016","journal-title":"Nat Med"},{"key":"2026041316530684000_ciag123-B35","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/thoraxjnl-2021-217190","article-title":"Respiratory symptoms and lung function in patients treated for pulmonary tuberculosis in Malawi: a prospective cohort study","volume":"77","author":"Nightingale","year":"2022","journal-title":"Thorax"},{"key":"2026041316530684000_ciag123-B36","doi-asserted-by":"crossref","first-page":"e0184530","DOI":"10.1371\/journal.pone.0184530","article-title":"Factors associated with pulmonary impairment in HIV-infected South African adults","volume":"12","author":"Gupte","year":"2017","journal-title":"PLoS One"},{"key":"2026041316530684000_ciag123-B37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/thoraxjnl-2019-213808","article-title":"Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study","volume":"75","author":"Meghji","year":"2020","journal-title":"Thorax"},{"key":"2026041316530684000_ciag123-B38","author":"Gupte"},{"key":"2026041316530684000_ciag123-B39","doi-asserted-by":"crossref","first-page":"e612","DOI":"10.1093\/cid\/ciaf353","article-title":"A point-of-care prediction tool for recurrent tuberculosis","volume":"81","author":"Cox","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026041316530684000_ciag123-B40","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2147\/COPD.S128750","article-title":"Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study","volume":"12","author":"Kim","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026041316530684000_ciag123-B41","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.5588\/ijtld.22.0075","article-title":"A scoping review of interventions to mitigate common non-communicable diseases among people with TB","volume":"26","author":"Romanowski","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026041316530684000_ciag123-B42","doi-asserted-by":"crossref","first-page":"102646","DOI":"10.1016\/j.eclinm.2024.102646","article-title":"A scoping review of interventions to address TB associated respiratory disability","volume":"73","author":"Mbanje","year":"2024","journal-title":"eClinicalMedicine"},{"key":"2026041316530684000_ciag123-B43","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1378\/chest.123.6.1988","article-title":"The effect of pulmonary rehabilitation in patients with post-tuberculosis lung disorder","volume":"123","author":"Ando","year":"2003","journal-title":"Chest"},{"key":"2026041316530684000_ciag123-B44","first-page":"55","article-title":"A randomized study of the effects of corticosteroid therapy on healing of pulmonary tuberculosis as judged by clinical, roentgenographic, and physiologic measurements","volume":"88","author":"Marcus","year":"1963","journal-title":"Am Rev Respir Dis"},{"key":"2026041316530684000_ciag123-B45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archinte.1961.03620090025004","article-title":"Corticotropin in the treatment of tuberculosis. A controlled study","volume":"108","author":"Angel","year":"1961","journal-title":"Arch Intern Med"},{"key":"2026041316530684000_ciag123-B46","first-page":"13","article-title":"Tuberculosis, corticosteroid therapy, and pulmonary function","volume":"100","author":"Malik","year":"1969","journal-title":"Am Rev Respir Dis"},{"key":"2026041316530684000_ciag123-B47","doi-asserted-by":"crossref","first-page":"1901692","DOI":"10.1183\/13993003.01692-2019","article-title":"The effect of HIV-associated tuberculosis, tuberculosis-IRIS and prednisone on lung function","volume":"55","author":"Stek","year":"2020","journal-title":"Eur Respir J"},{"key":"2026041316530684000_ciag123-B48","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S2213-2600(20)30448-3","article-title":"Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial","volume":"9","author":"Wallis","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2026041316530684000_ciag123-B49","doi-asserted-by":"crossref","first-page":"EVIDoa2300332","DOI":"10.1056\/EVIDoa2300332","article-title":"Adjunctive N-acetylcysteine and lung function in pulmonary tuberculosis","volume":"3","author":"Wallis","year":"2024","journal-title":"NEJM Evidence"},{"key":"2026041316530684000_ciag123-B50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/STROKEAHA.109.567735","article-title":"Tuberculosis and the risk of ischemic stroke: a 3-year follow-up study","volume":"41","author":"Sheu","year":"2010","journal-title":"Stroke"},{"key":"2026041316530684000_ciag123-B51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5588\/ijtld.13.0288","article-title":"Tuberculosis increases the subsequent risk of acute coronary syndrome: a nationwide population-based cohort study","volume":"18","author":"Chung","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026041316530684000_ciag123-B52","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1017\/S0950268817000279","article-title":"Tuberculosis and risk of acute myocardial infarction: a propensity score-matched analysis","volume":"145","author":"Huaman","year":"2017","journal-title":"Epidemiol Infect"},{"key":"2026041316530684000_ciag123-B53","doi-asserted-by":"crossref","first-page":"e0235821","DOI":"10.1371\/journal.pone.0235821","article-title":"Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: a systematic review and meta-analysis","volume":"15","author":"Basham","year":"2020","journal-title":"PLoS One"},{"key":"2026041316530684000_ciag123-B54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/cid\/ciae538","article-title":"Tuberculosis and increased incidence of cardiovascular disease: cohort study using United States and United Kingdom health records","volume":"80","author":"Critchley","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026041316530684000_ciag123-B55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40794-015-0014-5","article-title":"Tuberculosis and cardiovascular disease: linking the epidemics","volume":"1","author":"Huaman","year":"2015","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"2026041316530684000_ciag123-B56","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/s41598-017-01767-4","article-title":"Systems immunology of diabetes-tuberculosis comorbidity reveals signatures of disease complications","volume":"7","author":"Prada-Medina","year":"2017","journal-title":"Sci Rep"},{"key":"2026041316530684000_ciag123-B57","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.18632\/aging.203936","article-title":"Increased DNA methylation, cellular senescence and premature epigenetic aging in guinea pigs and humans with tuberculosis","volume":"14","author":"Bobak","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"2026041316530684000_ciag123-B58","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1172\/JCI134622","article-title":"DNA hypermethylation during tuberculosis dampens host immune responsiveness","volume":"130","author":"DiNardo","year":"2020","journal-title":"J Clin Invest"},{"key":"2026041316530684000_ciag123-B59","doi-asserted-by":"crossref","first-page":"607957","DOI":"10.3389\/fimmu.2020.607957","article-title":"Mycobacterium bovis Bacille-Calmette-Guerin infection aggravates atherosclerosis","volume":"11","author":"Huaman","year":"2020","journal-title":"Front Immunol"},{"key":"2026041316530684000_ciag123-B60","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1017\/S0950268823000559","article-title":"Role of latent tuberculosis infection on elevated risk of cardiovascular disease: a population-based cohort study of immigrants in British Columbia, Canada, 1985\u20132019","volume":"151","author":"Hossain","year":"2023","journal-title":"Epidemiol Infect"},{"key":"2026041316530684000_ciag123-B61","doi-asserted-by":"crossref","first-page":"e3384","DOI":"10.1093\/cid\/ciaa1934","article-title":"Latent tuberculosis infection and subclinical coronary atherosclerosis in Peru and Uganda","volume":"73","author":"Huaman","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026041316530684000_ciag123-B62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12872-024-03877-0","article-title":"The burden and natural history of cardiac pathology at TB diagnosis in a high-HIV prevalence district in Zambia: protocol for the TB-Heart study","volume":"24","author":"Scopazzini","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"2026041316530684000_ciag123-B63","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11904-013-0168-6","article-title":"Cardiovascular disease and HIV infection","volume":"10","author":"Triant","year":"2013","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2026041316530684000_ciag123-B64","volume-title":"WHO operational handbook on TB and comorbidities","year":"2025"},{"key":"2026041316530684000_ciag123-B65","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"2026041316530684000_ciag123-B66","doi-asserted-by":"crossref","first-page":"220025","DOI":"10.1183\/16000617.0025-2022","article-title":"Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis","volume":"31","author":"Cabrera-Sanchez","year":"2022","journal-title":"Eur Respir Rev"},{"key":"2026041316530684000_ciag123-B67","doi-asserted-by":"crossref","first-page":"1700157","DOI":"10.1183\/13993003.00157-2017","article-title":"Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis","volume":"50","author":"Dobler","year":"2017","journal-title":"Eur Respir J"},{"key":"2026041316530684000_ciag123-B68","doi-asserted-by":"crossref","first-page":"375","DOI":"10.21037\/jtd.2020.01.38","article-title":"Effects of age on the association between pulmonary tuberculosis and lung cancer in a South Korean cohort","volume":"12","author":"An","year":"2020","journal-title":"J Thorac Dis"},{"key":"2026041316530684000_ciag123-B69","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.7150\/jca.37022","article-title":"Pulmonary tuberculosis is associated with elevated risk of lung cancer in Korea: the nationwide cohort study","volume":"11","author":"Oh","year":"2020","journal-title":"J Cancer"},{"key":"2026041316530684000_ciag123-B70","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/ijc.30384","article-title":"Tuberculosis, smoking and risk for lung cancer incidence and mortality","volume":"139","author":"Hong","year":"2016","journal-title":"Int J Cancer"},{"key":"2026041316530684000_ciag123-B71","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/cncr.25616","article-title":"Pulmonary tuberculosis increases the risk of lung cancer: a population-based cohort study","volume":"117","author":"Wu","year":"2011","journal-title":"Cancer"},{"key":"2026041316530684000_ciag123-B72","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1513\/AnnalsATS.202010-1240OC","article-title":"Pulmonary tuberculosis and the incidence of lung cancer among patients with chronic obstructive pulmonary disease","volume":"19","author":"Park","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2026041316530684000_ciag123-B73","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1186\/s12885-015-1847-z","article-title":"The effects of pulmonary diseases on histologic types of lung cancer in both sexes: a population-based study in Taiwan","volume":"15","author":"Huang","year":"2015","journal-title":"BMC Cancer"},{"key":"2026041316530684000_ciag123-B74","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.5588\/ijtld.14.0161","article-title":"Tuberculosis and risk of cancer: a Danish nationwide cohort study","volume":"18","author":"Simonsen","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026041316530684000_ciag123-B75","doi-asserted-by":"crossref","first-page":"757","DOI":"10.5588\/ijtld.15.0783","article-title":"Incidence of lung cancer among patients with tuberculosis: a nationwide cohort study in Lithuania","volume":"20","author":"Everatt","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026041316530684000_ciag123-B76","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1158\/1055-9965.EPI-10-1166","article-title":"Increased risk of lung cancer in men with tuberculosis in the alpha-tocopherol, beta-carotene cancer prevention study","volume":"20","author":"Shiels","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026041316530684000_ciag123-B77","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.lungcan.2011.12.008","article-title":"History of tuberculosis as an independent prognostic factor for lung cancer survival","volume":"76","author":"Heuvers","year":"2012","journal-title":"Lung Cancer"},{"key":"2026041316530684000_ciag123-B78","doi-asserted-by":"crossref","first-page":"772211","DOI":"10.3389\/fcell.2021.772211","article-title":"Epigenetic signaling of cancer stem cells during inflammation","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026041316530684000_ciag123-B79","doi-asserted-by":"crossref","first-page":"1561719","DOI":"10.3389\/fimmu.2025.1561719","article-title":"Where lung cancer and tuberculosis intersect: recent advances","volume":"16","author":"Fang","year":"2025","journal-title":"Front Immunol"},{"key":"2026041316530684000_ciag123-B80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13550-020-0591-9","article-title":"Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response","volume":"10","author":"Malherbe","year":"2020","journal-title":"EJNMMI Res"},{"key":"2026041316530684000_ciag123-B81","doi-asserted-by":"crossref","first-page":"e46477","DOI":"10.7554\/eLife.46477","article-title":"Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity","volume":"8","author":"Kumar","year":"2019","journal-title":"Elife"},{"key":"2026041316530684000_ciag123-B82","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.21037\/atm-20-2219","article-title":"Chronic obstructive pulmonary disease phenotypes: imprint on pharmacological and non-pharmacological therapy","volume":"8","author":"Bakeer","year":"2020","journal-title":"Ann Transl Med"},{"key":"2026041316530684000_ciag123-B83","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1164\/rccm.201611-2232PP","article-title":"Eosinophilic and noneosinophilic asthma","volume":"197","author":"Carr","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026041316530684000_ciag123-B84","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM198312013092209","article-title":"Hormone receptors and breast cancer","volume":"309","author":"Manni","year":"1983","journal-title":"N Engl J Med"},{"key":"2026041316530684000_ciag123-B85","doi-asserted-by":"crossref","first-page":"e86017","DOI":"10.1172\/jci.insight.86017","article-title":"The antifibrotic drug pirfenidone promotes pulmonary cavitation and drug resistance in a mouse model of chronic tuberculosis","volume":"1","author":"Ahidjo","year":"2016","journal-title":"JCI Insight"},{"key":"2026041316530684000_ciag123-B86","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1164\/rccm.202208-1543OC","article-title":"The long-term impact of early-life tuberculosis disease on child health: a prospective birth cohort study","volume":"207","author":"Martinez","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026041316530684000_ciag123-B87","doi-asserted-by":"crossref","first-page":"103107","DOI":"10.1016\/j.eclinm.2025.103107","article-title":"Tuberculosis-associated respiratory impairment and disability in children and adolescents: a systematic review","volume":"81","author":"Romanowski","year":"2025","journal-title":"EClinicalMedicine"},{"key":"2026041316530684000_ciag123-B88","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1016\/S1473-3099(23)00004-X","article-title":"Post-tuberculosis sequelae in children and adolescents: a systematic review","volume":"23","author":"Igbokwe","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2026041316530684000_ciag123-B89","first-page":"55","article-title":"Post-tuberculosis lung disease in children and adolescents: a scoping review of definitions, measuring tools, and research gaps","volume":"53","author":"Nkereuwem","year":"2025","journal-title":"Paediatr Respir Rev"},{"key":"2026041316530684000_ciag123-B90","doi-asserted-by":"crossref","first-page":"102339","DOI":"10.1016\/j.eclinm.2023.102339","article-title":"Early life exposures contributing to accelerated lung function decline in adulthood\u2014a follow-up study of 11,000 adults from the general population","volume":"66","author":"Kirkeleit","year":"2023","journal-title":"eClinicalMedicine"},{"key":"2026041316530684000_ciag123-B91","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-7525-7-14","article-title":"Measuring health-related quality of life in tuberculosis: a systematic review","volume":"7","author":"Guo","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"2026041316530684000_ciag123-B92","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-244X-12-89","article-title":"Prevalence of psychological distress and associated factors in tuberculosis patients in public primary care clinics in South Africa","volume":"12","author":"Peltzer","year":"2012","journal-title":"BMC Psychiatry"},{"key":"2026041316530684000_ciag123-B93","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1186\/s12913-023-09835-4","article-title":"Using a theory-informed approach to guide the initial development of a post-tuberculosis care package in British Columbia, Canada","volume":"23","author":"Romanowski","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"2026041316530684000_ciag123-B94","doi-asserted-by":"crossref","first-page":"23992026211011314","DOI":"10.1177\/23992026211011314","article-title":"Impact of integrating mental health services within existing tuberculosis treatment facilities","volume":"5","author":"Pasha","year":"2021","journal-title":"Med Access Point Care"},{"key":"2026041316530684000_ciag123-B95","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/00333549101250S407","article-title":"Tuberculosis and stigmatization: pathways and interventions","volume":"125","author":"Courtwright","year":"2010","journal-title":"Public Health Rep"},{"key":"2026041316530684000_ciag123-B96","doi-asserted-by":"crossref","first-page":"727","DOI":"10.5588\/ijtldopen.25.0637","article-title":"Proceedings from the Third International Post-Tuberculosis Symposium: expanding the circle","volume":"2","author":"Allwood","year":"2025","journal-title":"IJTLD Open"},{"key":"2026041316530684000_ciag123-B97","article-title":"Post-tuberculosis lung disease: a case definition for use in research studies","volume":"25","author":"Bisson","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2026041316530684000_ciag123-B98","volume-title":"Integrated approach to tuberculosis and lung health","year":"2025"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_2\/S60\/68070123\/ciag123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_2\/S60\/68070123\/ciag123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T20:53:23Z","timestamp":1776113603000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/Supplement_2\/S60\/8653243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":98,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2026,4,13]]},"published-print":{"date-parts":[[2026,4,13]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag123","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,15]]},"published":{"date-parts":[[2026,4,13]]}}}